Economic evaluation of an adjunctive intraocular and peri-ocular steroid vitreoretinal surgery for open globe trauma: Cost-effectiveness of the ASCOT randomised controlled trial
Though there is no formally accepted cost-effectiveness willingness-to-pay threshold for 10-letter or more improvement, the ASCOT intervention for open globe trauma is a low-cost intervention. The ASCOT intervention is not cost-effective when compared to the standard care in this group and setting. The proportion of patients in the ASCOT intervention arm with 10 or more letter improvement produced some positive results but this is outweighed by the costs.
Authors
- Joanna Kelly (ORCID: https://orcid.org/0000-0002-4389-5284)
- Bethany Anthony (ORCID: https://orcid.org/0000-0002-2593-1069)
- Elizabeth Robertson (ORCID: https://orcid.org/0000-0002-2880-2086)
- Victory Ezeofor (ORCID: https://orcid.org/0000-0002-4211-8942)
- Victoria Cornelius (ORCID: https://orcid.org/0000-0002-0080-1065)
- Lucy Bryning
- Caroline Murphy (ORCID: https://orcid.org/0000-0001-7547-8998)
- Catey Bunce (ORCID: https://orcid.org/0000-0002-0935-3713)
- Edward J. Casswell (ORCID: https://orcid.org/0000-0002-8837-9910)
- Suzie Cro (ORCID: https://orcid.org/0000-0002-6113-1173)
- Rhiannon Tudor Edwards (ORCID: https://orcid.org/0000-0003-4748-5730)
- David G. Charteris (ORCID: https://orcid.org/0000-0001-6267-4180)
- Philip J. Banerjee
Institutions
- National Health Service (GB)
- Bangor University (GB)
- King's College London (GB)
- Royal Marsden Hospital (GB)
- Moorfields Eye Hospital (GB)
- University College London (GB)
- Imperial College London (GB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1371/journal.pone.0311158
- Citations
- 1
- Primary Topic
- Traumatic Ocular and Foreign Body Injuries
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Health and Care Research Wales
- National Institute for Health and Care Research
- Health Technology Assessment Programme